AMDL's Recent U.S. Patent for Immunogene Therapy for Cancer Details Development of 'Humanized Mouse' to Assist Subsequent Human
02-Jun-2004 -
Tustin, Calif. AMDL, Inc.,
developer and marketer of tests for the early detection of cancer and other
serious diseases, which recently announced it launched a major effort to seek
a strategic partner for clinical trials, and eventual marketing, of its unique
Combination Immunogene Therapy (CIT), ...
blood tests
clinical trials
diseases
+7